MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Cancer Genomics and Diagnostics
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,811 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,811 works in the cohort · of 4,299,418page 41 of 57

Labels cover 10 of 2,811 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,811 of 2,811 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Abstract 910: The cBioPortal for cancer genomics
Jianjiong Gao, Tali Mazor, Adam Abeshouse, Ersin Ciftci, Ino de Bruijn, Benjamin Groß +29 more
2019· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Supplementary Tables S1-S6, Figures S1-S2 from A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
Philippe L. Bédard, Josep Tabernero, Filip Jankú, Zev A. Wainberg, Luis Paz‐Ares, Johan Vansteenkiste +12 more
2023· supplementary-materials· en· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
affunlabeled
Identifying Actionable Targets in Cancer Patients
David Uehling, Janet Dancey, Andrew Brown, John D. McPherson, Rima Al‐awar
2013· other· en· Methods and principles in medicinal chemistry· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Supplementary Tables S1-S6, Figures S1-S2 from A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
Philippe L. Bédard, Josep Tabernero, Filip Jankú, Zev A. Wainberg, Luis Paz‐Ares, Johan Vansteenkiste +12 more
2023· supplementary-materials· en· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
affunlabeled
Abstract LBA021: Immune resistance interrogation study (IRIS): Initial report of next generation sequencing (NGS) results in patients with primary versus acquired resistance to anti-PD1/L1 antibodies
Sofia Genta, Farnoosh Abbas Aghababazadeh, Ming‐Sound Tsao, Aaron R. Hansen, Marcus O. Butler, Albiruni Ryan Abdul Razak +8 more
2021· article· en· Molecular Cancer Therapeutics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About